Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to execute a small clinical proof of concept trial: To examine the
effects of losartan on mucociliary clearance (MCC) in patients not eligible for CFTR rescue
therapies
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Kansas Medical Center University of Miami